TCNNF - Company ID 0001754195
Trulieve Cannabis Corp. trades as TCNNF. In its fiscal 2025 annual report the company posted revenue of $1.18B, down 0.4% from the prior year and net income of -$116.38M. This page tracks Trulieve Cannabis Corp. through 391 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 6 fiscal years Trulieve Cannabis Corp.'s revenue grew from $252.82M to $1.18B, a compound annual growth rate of 29.3%. Net profit margin compressed from 21.0% to -9.9% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Quarterly report | 10-Q | 2026-05-07 |
| Major company event | 8-K | 2026-05-07 |
| Proxy materials | DEFA14A | 2026-04-29 |
| Annual report to shareholders | ARS | 2026-04-29 |
| Proxy statement | DEF 14A | 2026-04-29 |
| Major company event | 8-K | 2026-04-21 |
| Insider trade | 4 | 2026-03-17 |
| Insider trade | 4 | 2026-03-17 |
The largest companies sharing Trulieve Cannabis Corp.'s SEC industry classification (medicinal chemicals & botanical products).
Trulieve Cannabis Corp. reported revenue of $1.18B for fiscal year 2025, a decrease of 0.4% year over year.
In its latest fiscal year Trulieve Cannabis Corp. reported a net loss of $116.38M.